Beetz, Rolf
Antibiotic Prophylaxis in vesico-ureteral Reflux: Studies hardly comparableAKTUELLE UROLOGIE. Bd. 48. H. 3. 2017 S. 191-192
Hennermann, Julia B.; Goekce, Seyfullah; Weyer-Elberich, Veronika et al.
Arterial tortuosity is a new clinical feature in patients with mucopolysaccharidosis type IVAMOLECULAR GENETICS AND METABOLISM. Bd. 120. H. 1-2. 2017 S. S65-S65
Siedler, A.; Koch, J.; Ultsch, B. et al.
Background paper to the decision not to recommend a standard vaccination with the live attenuated herpes zoster vaccine for the elderly in Germany Statement of the German Standing Committee on Vaccination (STIKO) at the Robert Koch Institute (RKI)BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ. Bd. 60. H. 10. 2017 S. 1162-1179
Bergman, J.E.H.; Lutke, L.R.; Gans, R.O.B. et al.
Beta-blocker use in pregnancy and risk of specific congenital anomalies: a European case-malformed control study2017
Fischer, Jeannette; Paret, Claudia; El Malki, Khalifa et al.
CD19 Isoforms Enabling Resistance to CART-19 Immunotherapy Are Expressed in B-ALL Patients at Initial DiagnosisJOURNAL OF IMMUNOTHERAPY. Bd. 40. H. 5. 2017 S. 187-195
Ripperger, Tim; Bielack, Stefan S.; Borkhardt, Arndt et al.
Childhood cancer predisposition syndromes-A concise review and recommendations by the Cancer Predisposition Working Group of the Society for Pediatric Oncology and HematologyAMERICAN JOURNAL OF MEDICAL GENETICS PART A. Bd. 173. H. 4. 2017 S. 1017-1037
Giugliani, Roberto; Scarpa, Maurizio; Tylki-Szymanska, Anna et al.
Clinical outcomes after 3 years of idursulfase treatment in patients with MPS II: data from the Hunter Outcome Survey (HOS)MOLECULAR GENETICS AND METABOLISM. Bd. 120. H. 1-2. 2017 S. S56-S56
Hughes, D.; Giugliani, R.; Guffon, N. et al.
Clinical outcomes in a subpopulation of adults with Morquio A syndrome: results from a long-term extension study of elosulfase alfaORPHANET JOURNAL OF RARE DISEASES. Bd. 12. 2017
Muenzer, Joseph; Giugliani, Roberto; Scarpa, Maurizio et al.
Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)ORPHANET JOURNAL OF RARE DISEASES. Bd. 12. 2017
Gal, Andreas; Beck, Michael; Hoeppner, Wolfgang et al.
Clinical utility gene card for: Fabry disease - update 2016EUROPEAN JOURNAL OF HUMAN GENETICS. Bd. 25. H. 7. 2017 S. E1-E3